rs121909053
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_001122752.2(SERPINI1):c.1175G>A(p.Gly392Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G392R) has been classified as Pathogenic.
Frequency
Consequence
NM_001122752.2 missense
Scores
Clinical Significance
Conservation
Publications
- progressive myoclonus epilepsyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- familial encephalopathy with neuroserpin inclusion bodiesInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SERPINI1 | NM_001122752.2 | c.1175G>A | p.Gly392Glu | missense_variant | Exon 9 of 9 | ENST00000446050.7 | NP_001116224.1 | |
| SERPINI1 | NM_005025.5 | c.1175G>A | p.Gly392Glu | missense_variant | Exon 9 of 9 | NP_005016.1 | ||
| SERPINI1 | XM_017006618.3 | c.1175G>A | p.Gly392Glu | missense_variant | Exon 9 of 9 | XP_016862107.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SERPINI1 | ENST00000446050.7 | c.1175G>A | p.Gly392Glu | missense_variant | Exon 9 of 9 | 1 | NM_001122752.2 | ENSP00000397373.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial encephalopathy with neuroserpin inclusion bodies Pathogenic:3
- -
This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 392 of the SERPINI1 protein (p.Gly392Glu). This missense change has been observed in individual(s) with SERPINI1-related conditions (PMID: 12103288, 25401298, 28631894). ClinVar contains an entry for this variant (Variation ID: 7089). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SERPINI1 protein function. Experimental studies have shown that this missense change affects SERPINI1 function (PMID: 18940798, 19549782, 23814041, 26367528, 28363799). This variant disrupts the p.Gly392 amino acid residue in SERPINI1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 18591508, 28631894). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
- -
Abnormality of the nervous system Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at